NCT04374175Recruiting
SERum-bank for PANcreatic Cancer
Source: ClinicalTrials.gov · Last updated 18 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is about pancreatic cancer. If the diagnostic cancer is done at an early stage (\<2cm), the chances of recovery are very good. But the main problem is there is not any detections means for this cancer. Sadly, when there is a cancer diagnostic , it's already too late in the majority of cases, because the cancer is in an advanced case. Today, there is no any effective means of detection... Blood markers can be a simple means of early detection
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 28 Apr 2020
- Start date
- 1 Apr 2020
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Diseases
- Pancreatic cancer
- NCT number
- NCT04374175
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Apr 2020 to the primary completion date, 1 Jan 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Acute renal failure
- Acute renal failure
Age
- Other synchronous cancer or history of cancer \<5 years
- Other synchronous cancer or history of cancer \<5 years
Other
- Patient refusal
- Child-Pugh B or C cirrhosis
- Patient under guardianship or curators
- Language barrier
- CONTROL GROUP
- Patient refusal
- Child-Pugh B or C cirrhosis
- Patient under guardianship or curators
Who the study is looking for
- Documented adenocarcinoma (cytology / anatomopathology), all stages, except if the tumor is immediately resectable and does not require preoperative cytological evidence. In this case, the inclusion and the first collection of the sero bank is done preoperatively. The diagnostic confirmation will therefore be made post-operatively at the risk of being excluded in the event of a different diagnosis.
- At the start of treatment (before surgery / 1st course of chemotherapy)
- Age ≥ 18 years
- Patient affiliated or entitled to a social security system
- Age ≥ 40 years
- Patient affiliated or entitled to a social security system
- Digestive endoscopy for any reason other than cancer or chronic inflammatory bowel disease
Criteria the registry did not label
- ADENOCARCINOMA GROUP
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Saint-Etienne Coordinator of this site? Confirm its status | Saint-Etienne | France | Recruiting |
| Institut Cancérologique Lucien Newirth (ICLN) Coordinator of this site? Confirm its status | Saint-Priest-en-Jarez | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.